Login to Your Account

Polytherics Lands $20.8M to Fund Antitope Acquisition

By Nuala Moran
Staff Writer

Monday, July 29, 2013
LONDON – Polytherics Ltd. raised £13.5 million (US$20.8 million) in a private round to fund the acquisition of antibody engineering specialist Antitope Ltd. and provide working capital to build on the enlarged company's portfolio of antibody development technologies.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription